Volitionrx Ltd

Diagnostics & Research

Prices are adjusted according to historical splits.

Volitionrx Ltd Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$102.36 million
Book Value:
Revenue TTM:
Operating Margin TTM:
Gross Profit TTM:
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Volitionrx Ltd had its IPO on 2007-04-25 under the ticker symbol VNRX.

The company operates in the Healthcare sector and Diagnostics & Research industry. Volitionrx Ltd has a staff strength of 111 employees.

Stock update

Shares of Volitionrx Ltd opened at $1.34 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.3 - $1.38, and closed at $1.34.

This is a +2.29% increase from the previous day's closing price.

A total volume of 150,609 shares were traded at the close of the day’s session.

In the last one week, shares of Volitionrx Ltd have increased by +3.88%.

Volitionrx Ltd's Key Ratios

Volitionrx Ltd has a market cap of $102.36 million, indicating a price to book ratio of 35.2345 and a price to sales ratio of 563.9999.

In the last 12-months Volitionrx Ltd’s revenue was $518547 with a gross profit of $306392 and an EBITDA of $-33550996. The EBITDA ratio measures Volitionrx Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Volitionrx Ltd’s operating margin was -6672.04% while its return on assets stood at -83.32% with a return of equity of -730.06%.

In Q2, Volitionrx Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 444.1%.

Volitionrx Ltd’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $-0.56 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Volitionrx Ltd’s profitability.

Volitionrx Ltd stock is trading at a EV to sales ratio of 518.863 and a EV to EBITDA ratio of -3.4691. Its price to sales ratio in the trailing 12-months stood at 563.9999.

Volitionrx Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$27.56 million
Total Liabilities
$18.80 million
Operating Cash Flow
Capital Expenditure
Dividend Payout Ratio

Volitionrx Ltd ended 2023 with $27.56 million in total assets and $0 in total liabilities. Its intangible assets were valued at $27.56 million while shareholder equity stood at $5.84 million.

Volitionrx Ltd ended 2023 with $0 in deferred long-term liabilities, $18.80 million in other current liabilities, 78137.00 in common stock, $-185507956.00 in retained earnings and $0 in goodwill. Its cash balance stood at $19.74 million and cash and short-term investments were $19.74 million. The company’s total short-term debt was $1,464,947 while long-term debt stood at $2.45 million.

Volitionrx Ltd’s total current assets stands at $21.51 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $196487.00 compared to accounts payable of $3.49 million and inventory worth $1.02 million.

In 2023, Volitionrx Ltd's operating cash flow was $-301394.00 while its capital expenditure stood at $301394.

Comparatively, Volitionrx Ltd paid $0 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Volitionrx Ltd stock is currently trading at $1.34 per share. It touched a 52-week high of $2.74 and a 52-week low of $2.74. Analysts tracking the stock have a 12-month average target price of $4.86.

Its 50-day moving average was $1.31 and 200-day moving average was $1.78 The short ratio stood at 4.64 indicating a short percent outstanding of 0%.

Around 2417.2% of the company’s stock are held by insiders while 824.8% are held by institutions.

Frequently Asked Questions About Volitionrx Ltd

The stock symbol (also called stock or share ticker) of Volitionrx Ltd is VNRX

The IPO of Volitionrx Ltd took place on 2007-04-25

Similar Industry Stocks (Diagnostics & Research)

Last Price
Sanofi ADR (SNY)

Most Active

Last Price
Amyris Inc (AMRS)
Humbl Inc (HMBL)

Top Gainers

Last Price
Latch Inc (LTCHW)

Top Losers

Last Price


VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 worldwide. It offers Nu.Q Vet cancer screening blood test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer that detect cancer; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company is based in Henderson, Nevada.


13215 Bee Cave Parkway, Austin, TX, United States, 78738